×
验证码:
换一张
Forgotten Password?
Stay signed in
×
Log In
Chinese
|
English
中国科学院金属研究所机构知识库
Log In
Register
ALL
ORCID
Title
Creator
Subject Area
Keyword
Funding Project
Document Type
Source Publication
Indexed By
Publisher
Date Issued
Date Accessioned
MOST Discipline Catalogue
Study Hall
Image search
Paste the image URL
Home
Collections
Authors
DocType
Subjects
K-Map
News
Search in the results
Collection
Authors
Document Type
Journal a... [49]
Date Issued
2020 [3]
2017 [1]
2016 [4]
2015 [2]
2014 [1]
2013 [1]
More...
Language
英语 [35]
Source Publication
CHINESE JO... [9]
WORLD JOUR... [8]
ASIAN JOUR... [3]
CHINESE ME... [3]
ACTA PHARM... [2]
CANCER MAN... [2]
More...
Funding Project
[National ... [7]
National N... [2]
National N... [2]
Natural Sc... [2]
Natural Sc... [2]
Natural Sc... [2]
More...
Indexed By
CSCD [29]
SCI [3]
Funding Organization
National N... [2]
Natural Sc... [2]
Shenzhen S... [2]
Special pr... [2]
×
Knowledge Map
IMR OpenIR
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
QQ
Weibo
Feedback
Browse/Search Results:
1-10 of 49
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Author Ascending
Author Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Title Ascending
Title Descending
Issue Date Ascending
Issue Date Descending
Submit date Ascending
Submit date Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Regulatory T Cells in Cancer Immunotherapy: Basic Research Outcomes and Clinical Directions
期刊论文
CANCER MANAGEMENT AND RESEARCH, 2020, 卷号: 12, 页码: 10411-10421
Authors:
Zeng, Guoming
;
Jin, Libo
;
Ying, Qinsi
;
Chen, Haojie
;
Thembinkosi, Murinda Charmaine
;
Yang, Chunguang
;
Zhao, Jinlong
;
Ji, Hao
;
Lin, Sue
;
Peng, Renyi
;
Zhang, Maolan
;
Sun, Da
Favorite
  |  
View/Download:91/0
  |  
Submit date:2021/02/02
cancer immunotherapy
Treg cells
FoxP3
targeting Treg cells
anti-cancer
Regulatory T Cells in Cancer Immunotherapy: Basic Research Outcomes and Clinical Directions
期刊论文
CANCER MANAGEMENT AND RESEARCH, 2020, 卷号: 12, 页码: 10411-10421
Authors:
Zeng, Guoming
;
Jin, Libo
;
Ying, Qinsi
;
Chen, Haojie
;
Thembinkosi, Murinda Charmaine
;
Yang, Chunguang
;
Zhao, Jinlong
;
Ji, Hao
;
Lin, Sue
;
Peng, Renyi
;
Zhang, Maolan
;
Sun, Da
Favorite
  |  
View/Download:80/0
  |  
Submit date:2021/02/02
cancer immunotherapy
Treg cells
FoxP3
targeting Treg cells
anti-cancer
Long non-coding RNA AFAP1-AS1 accelerates the progression of melanoma by targeting miR-653-5p
期刊论文
BMC Cancer, 2020, 卷号: 20, 期号: 1
Authors:
Fei Liu
;
Lanting Hu
;
Yi Pei
;
Ke Zheng
;
Wei Wang
;
Shenglong Li
;
Enduo Qiu
;
Guanning Shang
;
Jiaming Zhang
;
Xiaojing Zhang
Favorite
  |  
View/Download:59/0
  |  
Submit date:2021/10/15
Immunological and virological characteristics of human immunodeficiency virus type 1 superinfection: implications in vaccine design
期刊论文
FRONTIERS OF MEDICINE, 2017, 卷号: 11, 期号: 4, 页码: 480-489
Authors:
Gao Yang
;
Tian Wen
;
Han Xiaoxu
;
Gao Feng
Favorite
  |  
View/Download:69/0
  |  
Submit date:2021/02/26
NEUTRALIZING ANTIBODY-RESPONSE
RAPID DISEASE PROGRESSION
INTRAVENOUS-DRUG-USERS
HIV-1 DUAL INFECTION
FEMALE SEX WORKERS
T-CELL RESPONSES
ANTIRETROVIRAL THERAPY
AMSTERDAM COHORT
HOMOSEXUAL-MEN
HIGH-RISK
human immunodeficiency virus type I
superinfection
incidence
immune response
Discovery of a new series of imidazo1,2-apyridine compounds as selective c-Met inhibitors
期刊论文
ACTA PHARMACOLOGICA SINICA, 2016, 卷号: 37, 期号: 5, 页码: 698-707
Authors:
Liu Tongchao
;
Peng Xia
;
Ma Yuchi
;
Ji Yinchun
;
Chen Danqi
;
Zheng Mingyue
;
Zhao Dongmei
;
Cheng Maosheng
;
Geng Meiyu
;
Shen Jingkang
;
Ai Jing
;
Xiong Bing
Favorite
  |  
View/Download:102/0
  |  
Submit date:2021/02/02
RECEPTOR TYROSINE KINASE
INVASIVE GROWTH
SCATTER FACTOR
CANCER
DOCKING
c-Met inhibitors
hepatocyte growth factor receptor
imidazo1,2-apyridine
anticancer agents
drug discovery
Discovery of a new series of imidazo1,2-apyridine compounds as selective c-Met inhibitors
期刊论文
ACTA PHARMACOLOGICA SINICA, 2016, 卷号: 37, 期号: 5, 页码: 698-707
Authors:
Liu Tongchao
;
Peng Xia
;
Ma Yuchi
;
Ji Yinchun
;
Chen Danqi
;
Zheng Mingyue
;
Zhao Dongmei
;
Cheng Maosheng
;
Geng Meiyu
;
Shen Jingkang
;
Ai Jing
;
Xiong Bing
Favorite
  |  
View/Download:89/0
  |  
Submit date:2021/02/02
RECEPTOR TYROSINE KINASE
INVASIVE GROWTH
SCATTER FACTOR
CANCER
DOCKING
c-Met inhibitors
hepatocyte growth factor receptor
imidazo1,2-apyridine
anticancer agents
drug discovery
Thalidomide-based Regimens for Elderly and/or Transplant Ineligible Patients with Multiple Myeloma: A Meta-analysis
期刊论文
Chinese Medical Journal, 2016, 卷号: 129, 期号: 3, 页码: 320-325
Authors:
Lyu WenWen
;
Zhao QingChun
;
Song DeHai
;
Zhang JinJie
;
Ding ZhaoXing
;
Li BaoYuan
;
Wei ChuanMei
Favorite
  |  
View/Download:79/0
  |  
Submit date:2021/02/02
Elderly
Medicine
R
Meta-analysis
Multiple Myeloma
Thalidomide
Netrin-1 attenuates the progression of renal dysfunction by blocking endothelial-to-mesenchymal transition in the 5
期刊论文
BMC Nephrology, 2016, 卷号: 17, 期号: 1
Authors:
Jiuxu Bai
;
Junfeng Hao
;
Xiaoling Zhang
;
Hanmin Cui
;
Jingming Han
;
Ning Cao
Favorite
  |  
View/Download:41/0
  |  
Submit date:2021/10/15
microRNA-218 suppresses the proliferation, invasion and promotes apoptosis of pancreatic cancer cells by targeting HMGB1
期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2015, 卷号: 27, 期号: 3, 页码: 247-257
Authors:
Liu Zhe
;
Xu Yuanhong
;
Long Jin
;
Guo Kejian
;
Ge Chunlin
;
Du Ruixia
Favorite
  |  
View/Download:71/0
  |  
Submit date:2021/02/02
GROUP BOX 1
EXPRESSION
GENE
ADENOCARCINOMA
PROGRESSION
INHIBITORS
BIOMARKERS
MANAGEMENT
MIGRATION
OPTIONS
Pancreatic cancer
microRNA-218 (miR-218)
proliferation
apoptosis
high mobility group box 1 (HMGB1)
microRNA-218 suppresses the proliferation, invasion and promotes apoptosis of pancreatic cancer cells by targeting HMGB1
期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2015, 卷号: 27, 期号: 3, 页码: 247-257
Authors:
Liu Zhe
;
Xu Yuanhong
;
Long Jin
;
Guo Kejian
;
Ge Chunlin
;
Du Ruixia
Favorite
  |  
View/Download:68/0
  |  
Submit date:2021/02/02
GROUP BOX 1
EXPRESSION
GENE
ADENOCARCINOMA
PROGRESSION
INHIBITORS
BIOMARKERS
MANAGEMENT
MIGRATION
OPTIONS
Pancreatic cancer
microRNA-218 (miR-218)
proliferation
apoptosis
high mobility group box 1 (HMGB1)